Details for New Drug Application (NDA): 020941
✉ Email this page to a colleague
The generic ingredient in ABREVA is docosanol. There are five drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the docosanol profile page.
Summary for 020941
Tradename: | ABREVA |
Applicant: | Haleon Us Holdings |
Ingredient: | docosanol |
Patents: | 0 |
Suppliers and Packaging for NDA: 020941
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ABREVA | docosanol | CREAM;TOPICAL | 020941 | NDA | Haleon US Holdings LLC | 0135-0200 | 0135-0200-01 | 2 g in 1 TUBE (0135-0200-01) |
ABREVA | docosanol | CREAM;TOPICAL | 020941 | NDA | Haleon US Holdings LLC | 0135-0200 | 0135-0200-03 | 2 g in 1 BOTTLE, PUMP (0135-0200-03) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | CREAM;TOPICAL | Strength | 10% | ||||
Approval Date: | Jul 25, 2000 | TE: | RLD: | Yes |
Expired US Patents for NDA 020941
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Haleon Us Holdings | ABREVA | docosanol | CREAM;TOPICAL | 020941-001 | Jul 25, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription